Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): findings from the United Kingdom randomised, controlled open-label, platform adaptive trial

Activity: Talk or presentation typesOral presentation


Named author on oral presentation at ECCMID 2023.
Period15 Apr 202318 Apr 2023
Event title33rd European Congress of Clinical Microbiology and Infectious Disease: 33rd ECCMID
Event typeConference


  • covid-19
  • Antimicrobials